Lundbeck
HLUN-B.CO
$4.71
Share price
-0.67%
Change (1 day)
-10.11%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
EPS for Lundbeck (HLUN-B.CO)
EPS in 2023 (TTM): $0.35
According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.35. In 2022 the company made an earnings per share (EPS) of $0.27 a decrease over its 2021 EPS that were of $0.60.
EPS history for Lundbeck from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.35 | 31.5% |
| 2022 | $0.27 | -55.47% |
| 2021 | $0.60 | -51.83% |
| 2020 | $1.25 | -28.01% |
| 2019 | $1.74 | -44.08% |
| 2018 | $3.12 | 51.94% |
| 2017 | $2.05 | 126.64% |
| 2016 | $0.90 | -120.84% |
| 2015 | -$4.34 | 5622.18% |
| 2014 | -$0.07586 | -110.03% |
| 2013 | $0.76 | -28.08% |
| 2012 | $1.05 | -52.1% |
| 2011 | $2.19 | -1.31% |
| 2010 | $2.22 | 15.61% |
| 2009 | $1.92 |